Ischemic Stroke in Young Tunisian Adults.


Journal

La Tunisie medicale
ISSN: 2724-7031
Titre abrégé: Tunis Med
Pays: Tunisia
ID NLM: 0413766

Informations de publication

Date de publication:
05 Apr 2024
Historique:
received: 21 07 2023
accepted: 26 02 2024
medline: 15 5 2024
pubmed: 15 5 2024
entrez: 15 5 2024
Statut: epublish

Résumé

Ischemic Stroke in young adults is a real public health problem; it's a major cause of disability, alters quality of life and has a great socio-economic impact. determine risk factors and specify the etiology of arterial ischemic stroke in young Tunisian adults. In this 5 years retrospective study (2015-2020), we included all young adults (18-50 years) admitted for arterial ischemic stroke (AIS). Risk factors were registered and analyzed. All patients were investigated using a standard protocol: biological tests, brain imaging, carotid ultrasound and cardiac assessment. Additional investigations were carried out at the discretion of the treating physician. The cause of ischemic stroke was classified according to the TOAST criteria. We collected 200 patients with AIS. The mean age was 41.37 years ± 6.99. Traditional vascular risk factors were observed in more than 1⁄4 patients. A definite cause of stroke was identified in 120 patients. Cardio-embolic causes were the most common among our patients (19%) followed by atherosclerosis of the large arteries (11.5%). Other determined etiologies were found in 27.5% of patients. The etiology remained unclear in 40% of cases: undetermined despite complete investigation in 17.5%, undetermined and incompletely investigated 14.5 % and more than one potential pathomechanisms in 8%. Through this study, we demonstrated the diversity of etiology of stroke in young Tunisian adults. Changes of lifestyle are responsible for the occurrence of the traditional risk factors at an early age. Rheumatic heart diseases remain a frequent cause of AIS in our area.

Identifiants

pubmed: 38746961
pii: /article/view/4460
doi: 10.62438/tunismed.v102i4.4460
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

217-222

Auteurs

Dhaker Turki (D)

Laboratory of neurogenetics, Parkinson's disease and cerebrovascular disease (LR-12-SP-19), Habib Bourguiba University Hospital, University of Sfax, Tunisia.
Clinical Investigation Center (CIC), Habib Bourguiba University Hospital, Sfax, Tunisia.

Salma Sakka (S)

Laboratory of neurogenetics, Parkinson's disease and cerebrovascular disease (LR-12-SP-19), Habib Bourguiba University Hospital, University of Sfax, Tunisia.

Lamia Mbarek (L)

Laboratory of neurogenetics, Parkinson's disease and cerebrovascular disease (LR-12-SP-19), Habib Bourguiba University Hospital, University of Sfax, Tunisia.

Faten Triki (F)

Department of cardiology, Hedi Cheker hospital, Sfax University, Sfax, Tunisia.

Mounir Ben Jemaa (M)

Department of infectious diseases, Hedi Cheker hospital, Sfax university, Sfax, Tunisia.

Khadija Moalla (K)

Laboratory of neurogenetics, Parkinson's disease and cerebrovascular disease (LR-12-SP-19), Habib Bourguiba University Hospital, University of Sfax, Tunisia.

Sameh Marzouk (S)

Hedi Chaker hospital, department of internal medicine, Sfax, Tunisia.

Olfa Turki (O)

Department of intensive care, Habib Bourguiba University Hospital, University, Sfax, Tunisia.

Fatma Megdiche (F)

Laboratory of hematology, Hbib Bourguiba University Hospital Sfax, Tunisia.

Choumous Kallel (C)

Laboratory of hematology, Hbib Bourguiba University Hospital Sfax, Tunisia.

Mariem Damak (M)

Laboratory of neurogenetics, Parkinson's disease and cerebrovascular disease (LR-12-SP-19), Habib Bourguiba University Hospital, University of Sfax, Tunisia.

Chokri Mhiri (C)

Laboratory of neurogenetics, Parkinson's disease and cerebrovascular disease (LR-12-SP-19), Habib Bourguiba University Hospital, University of Sfax, Tunisia.
Clinical Investigation Center (CIC), Habib Bourguiba University Hospital, Sfax, Tunisia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH